Samuel Fortin

841 total citations
33 papers, 693 citations indexed

About

Samuel Fortin is a scholar working on Nutrition and Dietetics, Biochemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Samuel Fortin has authored 33 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nutrition and Dietetics, 12 papers in Biochemistry and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Samuel Fortin's work include Fatty Acid Research and Health (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Pulmonary Hypertension Research and Treatments (6 papers). Samuel Fortin is often cited by papers focused on Fatty Acid Research and Health (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Pulmonary Hypertension Research and Treatments (6 papers). Samuel Fortin collaborates with scholars based in Canada, Australia and Russia. Samuel Fortin's co-authors include Éric Rousseau, Caroline Morin, Caroline Morin, Pierre Blier, André M. Cantin, Roddy Hiram, Marco Sirois, Jean-François Lavallée, Rabindra Rej and Pierre Payment and has published in prestigious journals such as Journal of the American Chemical Society, Applied and Environmental Microbiology and Journal of Lipid Research.

In The Last Decade

Samuel Fortin

32 papers receiving 674 citations

Peers

Samuel Fortin
Michael J. Thomas United States
Samuel Fortin
Citations per year, relative to Samuel Fortin Samuel Fortin (= 1×) peers Michael J. Thomas

Countries citing papers authored by Samuel Fortin

Since Specialization
Citations

This map shows the geographic impact of Samuel Fortin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Fortin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Fortin more than expected).

Fields of papers citing papers by Samuel Fortin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Fortin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Fortin. The network helps show where Samuel Fortin may publish in the future.

Co-authorship network of co-authors of Samuel Fortin

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Fortin. A scholar is included among the top collaborators of Samuel Fortin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Fortin. Samuel Fortin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Génard, Bertrand, et al.. (2025). “Bleu VS Yellow”: Marennine and extracellular polysaccharides for potential application in cosmetic and pharmaceutical applications. The Microbe. 8. 100448–100448. 1 indexed citations
2.
Alata, Waël, Carl Julien, Vincent Émond, et al.. (2024). Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer’s disease. Journal of Lipid Research. 65(12). 100682–100682.
3.
Dufresne, France, Jean‐Claude Tardif, Johnny Huard, et al.. (2024). Mitochondrial functions and fatty acid profiles in fish heart: an insight into physiological limitations linked to thermal tolerance and age. Journal of Experimental Biology. 227(20). 5 indexed citations
4.
Young, Nathan, et al.. (2019). “Consulted to death”: Personal stress as a major barrier to environmental co-management. Journal of Environmental Management. 254. 109820–109820. 18 indexed citations
5.
Morin, Caroline, et al.. (2017). Eicosapentaenoic acid monoglyceride resolves inflammation in an ex vivo model of human peripheral blood mononuclear cell. European Journal of Pharmacology. 807. 205–211. 13 indexed citations
6.
Morin, Caroline & Samuel Fortin. (2017). Docosahexaenoic Acid Monoglyceride Increases Carboplatin Activity in Lung Cancer Models by Targeting EGFR. Anticancer Research. 37(11). 6015–6023. 14 indexed citations
7.
Morin, Caroline, Enrique Rodríguez–Borja, Pierre Blier, & Samuel Fortin. (2017). Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer. Marine Drugs. 15(9). 283–283. 23 indexed citations
8.
Hiram, Roddy, Caroline Morin, Samuel Fortin, & Éric Rousseau. (2016). MAG-DHA, Precursor of D-Series Resolvins, Induces Powerful Resolution of Various Components of Pulmonary Hypertension Induced By Monocrotaline in Rats. 1(2). 27–35. 3 indexed citations
9.
Kim, Gilbert, et al.. (2016). Comparison of the effects of EPA and DHA alone or in combination in a murine model of myocardial infarction. Prostaglandins Leukotrienes and Essential Fatty Acids. 111. 11–16. 20 indexed citations
10.
Morin, Caroline, et al.. (2015). Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 53(4). 574–583. 17 indexed citations
11.
Morin, Caroline, Pierre Blier, & Samuel Fortin. (2015). Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model. Arthritis Research & Therapy. 17(1). 142–142. 53 indexed citations
12.
Hiram, Roddy, et al.. (2015). Resolvin E1normalizes contractility, Ca2+sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries. American Journal of Physiology-Lung Cellular and Molecular Physiology. 309(8). L776–L788. 41 indexed citations
13.
Morin, Caroline, Éric Rousseau, Pierre Blier, & Samuel Fortin. (2015). Effect of docosahexaenoic acid monoacylglyceride on systemic hypertension and cardiovascular dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 309(1). H93–H102. 30 indexed citations
14.
Morin, Caroline, et al.. (2013). Anti-Cancer Effects of a New Docosahexaenoic Acid Monoacylglyceride in Lung Adenocarcinoma. Recent Patents on Anti-Cancer Drug Discovery. 8(3). 319–334. 22 indexed citations
15.
Morin, Caroline, Éric Rousseau, & Samuel Fortin. (2013). Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells. Prostaglandins Leukotrienes and Essential Fatty Acids. 89(4). 203–213. 51 indexed citations
16.
Morin, Caroline, Samuel Fortin, & Éric Rousseau. (2012). Bronchial inflammation induced PKCζ over-expression: involvement in mechanical properties of airway smooth muscle. Canadian Journal of Physiology and Pharmacology. 90(2). 261–269. 12 indexed citations
17.
Morin, Caroline, Samuel Fortin, & Éric Rousseau. (2012). Docosahexaenoic Acid Monoacylglyceride Decreases Endothelin-1 Induced Ca2+ Sensitivity and Proliferation in Human Pulmonary Arteries. American Journal of Hypertension. 25(7). 756–763. 17 indexed citations
18.
Morin, Caroline, Samuel Fortin, André M. Cantin, & Éric Rousseau. (2010). Docosahexaenoic Acid Derivative Prevents Inflammation and Hyperreactivity in Lung. American Journal of Respiratory Cell and Molecular Biology. 45(2). 366–375. 46 indexed citations
19.
Rej, Robert, et al.. (1996). ChemInform Abstract: Synthesis and in vitro Cytotoxicity of Cryptophycins and Related Analogues.. ChemInform. 27(37). 1 indexed citations
20.
Rej, Rabindra, et al.. (1996). Synthesis and in vitro cytotoxicity of cryptophycins and related analogs. Bioorganic & Medicinal Chemistry Letters. 6(10). 1111–1116. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026